FDA Expected To Approve Esketamine Nasal Spray For Depression : Shots - Health News Three decades after Prozac arrived, a new kind of antidepressant. And it's based on the party drug "Special K."
NPR logo

FDA Expected To Approve Esketamine Nasal Spray For Depression

  • Download
  • <iframe src="https://www.npr.org/player/embed/700014137/701053875" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
FDA Expected To Approve Esketamine Nasal Spray For Depression

FDA Expected To Approve Esketamine Nasal Spray For Depression

FDA Expected To Approve Esketamine Nasal Spray For Depression

  • Download
  • <iframe src="https://www.npr.org/player/embed/700014137/701053875" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The Food and Drug Administration is expected to approve a new type of drug for depression. It is esketamine, a chemical cousin of the anesthetic and party drug ketamine.